Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome back to the Deep Dive.
Today, we're diving into some really critical pharmacology territory.
We're taking expert nursing texts and boiling them down to the essentials on endocrine drugs.
That's the plan.
We're focusing on two really major systems, the thyroid gland and the pancreas, specifically how we manage diabetes.
We'll be pulling out the mechanisms, those tricky dosing rules, side effects, and maybe most importantly, the key nursing safety points you absolutely need to know.
Exactly, because when you're dealing with hormones, you're adjusting the body's core regulators.
Precision is everything.
Let's kick things off with the thyroid, the body's sort of thermostat and metabolic engine, right?
That's a great analogy.
The thyroid gland pumps out thyroxine, which is T4, and triodothyronine, T3.
These hormones, they basically set your basal metabolic rate, manage how you process fats and carbs, and even control body temperature.
And the whole process needs iodine.
It does, just a tiny bit, about one milligram a week from your diet.
This iodide gets coupled with an amino acid, tyrosine, and the pituitary gland sends out thyroid stimulating hormone, TSH, to sort of get that process started.
It's interesting that T3 is way more potent, like four times stronger.
Yeah.
But we have much more T4 circulating.
Yeah, the body maintains that specific balance.
T4 acts almost like a reservoir that can be converted to the more active T3 when knitted.
So what happens when that system goes wrong?
Let's start with hypothyroidism.
Okay, so hypothyroidism means the gland isn't producing enough T3 and T4.
The most common form is primary hypothyroidism.
The problem's right in the thyroid gland itself.
And the symptoms are like everything's slowing down, feeling cold, gaining weight, fatigue,
brittle hair, and nails.
Precisely.
In adults, severe long -term hypothyroidism leads to a condition called myxedema.
It's a real systemic slowdown.
And the flip side, hyperthyroidism.
That's when you've got way too much T3 and T4, often caused by Graves' disease, which is an autoimmune issue.
Symptoms are the exact opposite.
Feeling hot, anxious, trouble sleeping, heart palpitations, diarrhea,
increased appetite, but often losing weight.
And that can escalate badly, right?
To thyroid storm.
Yes.
Thyroid storm is a life -threatening emergency, usually triggered by something like major stress or an infection in someone who already has hyperthyroidism.
It's like the body goes into extreme overdrive.
Okay.
So treating the low -side hypothyroidism, the main drug is levothyroxine.
Why is that the preferred one?
Levothyroxine is synthetic T4.
It's preferred because it's chemically pure, just 100 % T4.
This makes its effects really predictable and easier to monitor with blood tests.
How does it work?
This replaces the missing hormone.
Essentially, yes.
It mimics the natural T4.
So it boosts metabolic rate, increases oxygen use.
And this is really important.
It stimulates the heart by increasing the number of beta adrenergic receptors on the heart muscle.
Ah, so that's where the whisk comes in if the dose is too high.
The cardiac effects.
Exactly.
The most significant adverse effect of too much levothyroxine is cardiac dysrhythmia.
That increased sensitivity to adrenaline and noradrenaline, the catecholamines, can really destabilize the heart rhythm.
And this leads us to that critical dosing safety alert.
The microgram versus milligram issue.
This is huge.
Levothyroxine is dosed in micrograms MCG.
You really need to question any dose ordered over 200 milligrams.
A very common and potentially fatal error is writing MG for milligrams instead of MCG.
That's a thousand -fold overdose just from misreading two letters.
A thousand times the intended dose.
It's a massive safety focus in nursing.
You have to be vigilant about that unit.
Beyond the dose itself, the timing of administration is also super specific.
Why is that?
Absorption is key.
To get consistent absorption, levothyroxine must be taken first thing in the morning on a completely empty stomach.
Wait at least 30 to 60 minutes before eating or drinking anything besides water.
And taking it later can cause issues.
Yeah.
Taking it later in the day can definitely interfere with sleep because of that metabolic boost it provides.
Consistency is really the name of the game.
Same time, empty stomach, every day.
Okay.
Now let's switch gears to hyperthyroidism treatment.
The anti -thyroid drugs like PTU and methamazole.
How do they work?
These drugs basically interfere with the production of thyroid hormones.
They inhibit the enzyme that incorporates iodine into tyrosine.
So T3 and T4 just don't get made properly.
You mentioned PTU has an extra trick.
Right.
Propylthrosol or PTU also blocks the conversion of T4 into the more potent T3 in the peripheral tissues.
Methamazole doesn't do that second part.
What are the big safety concerns with these anti -thyroid drugs?
The major worries are liver toxicity and bone marrow toxicity.
Specifically, they can cause agranulocytosis, which is a dangerous drop in white blood cells, or leukopenia, a general decrease.
So patients need specific instructions.
Absolutely.
You have to teach them to report any signs of infection immediately.
Fever, sore throat, unusual fatigue or bleeding.
That could signal bone marrow suppression.
And another key point, they need to avoid foods high in iodine.
Like shellfish and iodized salt, because that would counteract the drug.
Exactly.
The drug works by blocking iodine use.
So flooding the system with iodine makes the drug less effective.
Wow.
So with thyroid meds, it's all about precision dose, timing,
monitoring for specific toxicities.
Let's see how this level of detail applies to our second big area, the pancreas and diabetes management.
Okay, the pancreas.
Its main job in glucose control involves the islets of Langerhans.
You've got alpha cells making glucagon, which raises blood sugar, and beta cells making insulin, which lowers it.
Keeping things in that sweet spot.
Ideally, 70 to 100 ml of GDL fasting.
Right.
Insulin basically unlocks the door for glucose to get into cells for energy, or it helps store glucose as glycogen in the liver and muscles, or as fat.
Let's talk about the types of diabetes.
Type 1 is pretty clear cut, isn't it?
Yeah.
Type 1 diabetes is an autoimmune disease where the body destroys its own beta cells.
So there's an absolute lack of insulin.
These patients need exogenous insulin to survive.
They're also prone to diabetic ketoacidosis, or DKA.
DKO, that's the ketones and acidosis from breaking down fat, because there's no insulin to use glucose.
Correct.
Now type 2 diabetes is much more common, like 90 % of cases.
It usually involves insulin resistance.
The cells don't respond properly to insulin, and often the pancreas just can't produce enough insulin to keep up.
And it's strongly linked to obesity and metabolic syndrome.
Can type 2 patients get DKA too?
I thought that was more type 1.
That's a really good point.
While type 2 is more classically associated with HHS hyperosmolar hyperglycemic syndrome, which is severe dehydration and very high blood sugar, without the acidosis under conditions of extreme stress, like a bad infection,
type 2 patients can develop DKA because their relative insulin efficiency becomes absolute.
Okay, got it.
So the goals for managing diabetes, according to the ADA, are a fasting glucose between 80 and 130 in that hemoglobin A1C.
Yeah, the A1C gives you about a three -month average of blood sugar control.
The goal is generally 7 % or less.
Let's get into the insulins required for type 1, often needed for type 2 eventually.
Right.
We use human recombinant insulins now.
They're classified mostly by how quickly they start working and how long they last.
So you have rapid acting insulins like Lispro and Aspart.
On set in about 15 minutes.
Yep, super fast.
Which means critically, you have to give it within 15 minutes of the patient starting their meal.
Not 30 minutes before, not an hour after, right around meal time to cover the glucose spike from food.
Okay.
Then there's short -acting, which is regular insulin.
This one has a really unique safety point.
This is a must -know fact for any nurse.
Regular insulin is the only insulin type that can be given intravenously, IV.
Why is that so important?
Because in emergencies like DKA, you need precise, rapid control of blood sugar, often with an ID drip.
Regular insulin is the formulation stable enough for IV use.
Makes sense.
What about the longer acting ones?
Next up is intermediate acting, NPH insulin.
It looks cloudy or opaque because it's a suspension.
It has a slower onset and last longer, maybe 10 to 18 hours.
And then the really long ones.
Those are the long acting insulins like Glargine and Dedimir.
Glargine, for example, is clear, looks like regular insulin, but it provides a steady, peakless level of basal insulin over about 24 hours.
It mimics the pancreas's background secretion.
And this basal insulin is key to the modern approach, basal bolus therapy.
Absolutely.
The preferred method now is basal bolus.
You use a long acting insulin once or twice a day for that constant background coverage.
That's the basal part.
Then you use a rapid acting insulin before meals.
And maybe for correction doses, if the sugar is high, that's the bolus.
Better than the old sliding scale method.
Oh, much better.
Sliding scale is purely reactive.
You wait for the sugar to go high, then you chase it with insulin.
It often leads to these big swings, high then low.
Basal bolus is proactive, aiming for steadier control.
We have to stress again, insulin is a high alert medication.
Extremely high alert.
Always, always check the blood glucose before giving any dose.
And double check the dose, the type of insulin, everything.
And the mixing rule, if you have to mix types.
Crucial.
If you're mixing, say, regular and NTH in the same syringe, you always drop the clear insulin, the regular or rapid acting first.
Then you drop the cloudy NPH insulin.
Why clear before cloudy?
To prevent any of the additives in the cloudy NPH suspension from getting into the clear vial.
Contaminating the clear vial could change how fast it works, which you don't want.
Clear before cloudy, always.
Got it.
Okay, let's move to the non -insulin drugs, mostly for type 2 diabetes.
Starting with the workhorse, metformin.
Metformin is usually the first line drug It's a big one -eyed.
Its main jobs are reducing glucose production by the liver and making the body's cells more sensitive to the insulin that's already there.
And a big plus is it usually doesn't cause weight gain or significant low blood sugar when used alone.
Right, those are major advantages, but it comes with a very serious warning.
The kidney issue.
Lactic acidosis.
Yes.
Lactic acidosis is rare, but potentially fatal.
Metformin is absolutely contraindicated in patients with significant renal disease or dysfunction, generally a creatinine clearance below 30 a million.
And there's a critical interaction with radiology procedures.
This requires sharp nursing assessment.
Metformin must be held before and for 48 hours after any procedure involving intravenous iodine -containing contrast dye, like for certain CT scans.
The contrast dye can temporarily affect kidney function, and if the patient is on metformin, this combination dramatically increases the risk of lactic acidosis.
You, the nurse, might be the last line of defense in catching this.
That's a huge responsibility coordinating across departments.
What about other older oral agents, sulfonylureas?
Sulfonylureas, like gliposide, work by stimulating the pancreas to release more insulin.
So they only work if the patient still has some functioning beta cells.
The downsides are risk of hypoglycemia and often some weight gain.
And the glinides.
Similar, but shorter acting.
Exactly.
Drugs like rapaglinide.
They also stimulate insulin release, but are much shorter acting.
They need to be taken with each meal.
The interesting part is, if the patient skips a meal, they must skip the dose.
This makes them useful for people with irregular eating schedules.
What about pheasolidinionis, the TZDs, like pio glitizum?
These are insulin sensitizers, similar to metformin in that effect, but they carry a significant black box warning because they can cause or worsen heart failure.
So they're generally avoided in patients with symptomatic heart failure.
Okay, now on to the newer classes that have really become game changers.
GLP -1 agonists.
Yeah, the glucagon -like peptide -1 agonists.
Think liraglutide, semaglutide.
Most are injectable, though an oral form of semaglutide exists now.
They do several things.
Enhance insulin secretion only when glucose is high, suppress glucagon release, slow down stomach emptying, which helps with satiety, and often lead to weight loss.
Sounds great, but there's a warning there too.
Yes, there's a black box warning regarding a risk of thyroid C cell tumors, based mostly on animal studies, but it's something to be aware of.
And the other big new class, the SGLT -2 inhibitors.
Sodium glucose co -transporter 2 inhibitors.
Drugs like Dapagliflozin and Pagliflozin.
These are fascinating because they work totally independently of insulin action.
How do they do that?
They block the reabsorption of glucose in the kidneys.
So instead of glucose going back into the blood, it gets spilled out into the urine, a condition called glycosuria.
And they have heart benefits.
Yes.
Several SGLT -2 inhibitors have shown significant cardiovascular benefits, reducing risks of heart failure hospitalization and cardiovascular death, which is a huge deal in diabetes.
But there must be side effects to peeing out sugar.
Definitely.
The main ones are an increased risk of genital yeast infections, because yeast loves sugar, and urinary tract infections.
There's also a small risk of a specific type of ketoacidosis, even with normal blood sugar levels sometimes, and concerns about dehydration.
Okay, before we wrap this section, managing the opposite problem.
Hypoglycemia.
Low blood sugar.
Below 70mgL.
This is a critical skill.
If the patient is conscious and can swallow, give them fast -acting oral glucose.
15 grams is the standard rule.
That could be glucose tablets, gel, juice, regular soda.
And if you're unconscious?
Then it's an emergency.
You can't give oral glucose.
The treatment is either IV dextrose, usually D50W, which is 50 % dextrose in water, or if IV access isn't available, a subcutaneous or intramuscular injection of glucagon.
Glucagon tells the liver to release stored glucose.
Is there any situation where juice wouldn't work for someone who is conscious?
Yes.
One specific case.
If the hypoglycemia is caused by a class of drugs called alpha -glucosidase inhibitors, like a carbose, these drugs block the breakdown of complex carbs in the gut.
So giving juice or sugar won't work quickly because it needs to be broken down first.
For these patients, you must use oral glucose tablets or gel or IV glucose if needed.
Simple glucose only.
That's a very specific but vital point.
Okay, let's try to tie this all together.
We've covered thyroid hormones and diabetes management.
Two massive areas.
And the common thread seems to be incredible precision.
Timing matters immensely.
Leave off thyroxine before breakfast.
Rapid insulin with the meal.
Dosing units matter MCG vs.
Mimigy can be life or death.
And understanding those specific organ toxicities – heart, kidney, liver, bone marrow – is non -negotiable.
Absolutely.
Knowing the drug is one thing, but knowing to hold metformin before contrast.
Knowing only regular insulin goes IV.
Knowing to check blood sugar before every insulin dose.
That's a critical application.
It really is.
These aren't just facts to memorize.
They are actions that directly impact patient safety every single day.
So here's something for you, our listener, to think about.
We've talked about high alert medications and critical thinking points, like questioning that high leave off thyroxine dose or remembering the metformin hold.
How does integrating that level of critical thought, and frankly, courage to question orders, elevate nursing practice from just following procedures to delivering truly professional safe care?
Is really the difference between being a task doer and being a clinical decision maker safeguarding the patient?
A powerful thought indeed.
Thank you so much for joining us on this deep dive into endocrine pharmacology.
We hope this helps clarify some complex topics.
We look forward to diving into more with you next time.